期刊文献+

糖基化终产物在糖尿病眼部并发症中的作用研究进展 被引量:4

Recent research on advanced glycation-end products in pathobiology of ocular complications of diabetes mellitus
下载PDF
导出
摘要 糖基化终产物(advanced glycation-end products,AGEs)是在持续高糖状态下,蛋白质的氨基与糖的醛基在非酶催化反应下生成的终产物,与糖尿病慢性并发症的发生发展密切相关。AGEs可以导致多种眼部疾病发生,如糖尿病性白内障、糖尿病视网膜病变、黄斑病变及青光眼等。本文就AGEs的生成及其参与糖尿病相关眼病的可能作用机制进行综述。 Advanced glycation-end products (AGEs) are the final products produced in the non-enzymatic catalysis reaction in the condition of continuous glucose, and play a critical role in the progression of chronic complications in diabetic mellitus. AGEs have been implicated in vision loss associated with diabetic cataract, diabetic retinopathy, macular degeneration and glaucoma. This article reviews recent research about the formation of AGEs and the correlation between eye diabetic diseases and AGEs.
作者 王旭 严宏
出处 《眼科新进展》 CAS 北大核心 2015年第8期787-790,共4页 Recent Advances in Ophthalmology
基金 国家自然科学基金资助(编号:81070720)~~
关键词 糖基化终产物 糖尿病性白内障 糖尿病视网膜病变 advanced glycation-end products diabetic cataract diabetic retinopathy
  • 相关文献

参考文献51

  • 1Fried LF, Emanuele N, Zhang JH, Brophy M, Conner TA, Duck- worth W, et al. Combined mgiotensin inhibition for the treat- ment of diabetic nephropathy [J]. N Engl J Med,2013,369 ( 20 ) : 1892-1903.
  • 2Kaushal S, Singh H, Thangaraju P, Singh J. Canagliflozin: A No- vel SGLT2 inhibitor for type 2 diabetes raellitus [ J ]. N Am J Med Sci,2014,6(3) :107-113.
  • 3Li H,Oldenburg B,Chamberlain C,O' Nell A,Xue B,Jolley D,et al. Diabetes prevalence and determinants in adults in China ma- inland from 2000 to 2010 : a systematic review [ J ]. Diabetes Res Clin Pratt,2012,98 (2) :226-235.
  • 4Zicari AM, Zieari A, Nebbioso M, Mari E, Celani C, Lollobrigida V,et al. High-mobility group box-I ( HMGB-1 ) and serum solu- ble receptor for advanced glyeation end products ( sRAGE ) in children affected by vernal keratoconjunctivitis [J]. Pediatr Al- lergy Immuno1,2014 ,25 (1) :57-63.
  • 5Semba RD, Cotch MF, Gudnason V, Eiriksdottir G, Harris TB, Sun K, et al. Serum earboxymethyllysine, an advanced glyeation end product, and age-related macular degeneration: the Age, Gene/Environment Suseeptibility-Reyavik Study [ J ]. JAMA Ophthalmo1,2014,132 ( 4 ) :464-470.
  • 6Singh VP, Bali A, Singh N, Jaggi AS. Advanced glycation end products and diabetic complications [ J ]. Korean J Physiol Pharmacol, 2014,18 ( 1 ) : 1-14.
  • 7Thorpe SR, Baynes JW. Role of the Maillard reaction in diabetes mellittm and diseases of aging [J]. Drags Aging, 1996,9 (2) :69- 77.
  • 8Vlassara H, Striker GE. AGE restriction in diabetes mellitus: a paradigm shift [J]. Nat Rev Endocrinol,2011 ,7(9) :526-539.
  • 9Kandarakis SA, Piperi C, Topouzis F, Papavassiliou AG. Emer- ging role of advanced glyeation-end products (AGEs) in the pathobiology of eye diseases [J]. Prog Retin Eye Res, 2014,42 ( 1 ) :85-102.
  • 10Ahmed N. Advanced glycation endproducts--role in pathology of diabetic complications[J]. Diabetes Res Clin Praet, 2005,67 (1) :3-21.

同被引文献42

引证文献4

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部